This is a preview of subscription content, log in via an institution to check access.
Notes
Camptosar is used to treat colorectal cancer and was relabeled recently to include dosing recommendations based on a patient’s genetic profile.
Stiffening of arteries indicates a loss of their elastic properties.
References
University of Illinois at Chicago. Genes may predict response to ADHD medication. Media release: 17 Aug 2005
University of Texas Medical Branch at Galveston. ‘Mad Cow’ proteins successfully detected in blood. Media release: 28 Aug 2005
Third Wave Technologies. Third Wave receives FDA clearance of pharmacogenetic test. Media release: 22 Aug 2005
US Food and Drug Administration. FDA clears genetic test that advances personalized medicine. Test helps determine safety of drug therapy. Media release: 22 Aug 2005
Biosite. Biosite(R) Incorporated receives CLIA waiver for Triage(R) BNP test. Media release: 29 Aug 2005
Thomas Jefferson University. Researchers find potential biomarker for heart failure. Media release: 19 Aug 2005
Mayo Clinic. Measuring C-reactive protein is early indicator of stiffened arteries. Media release: 22 Aug 2005
Rights and permissions
About this article
Cite this article
Diagnostic Developments. Pharmaceutical & Diagnostic Innovation 3, 20–22 (2005). https://doi.org/10.1007/BF03256995
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03256995